Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01806 |
| Species: | Homo sapiens |
| Position : | chr3:185824281-185824602 |
| Year: | 2024 |
| Title: | KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | tongue squamous cell carcinoma |
| PMID: | 38443991 |
| MONDO: | MONDO:0005084 |
| Tissue: | Tongue |
| Tissue Ontology ID: | UBERON:0001723 |
| Cell Source: | CAL27 |
| CVCL ID: | CVCL_1107 |
| Cell Type: | tongue squamous cell carcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR, Western blot |
| Target gene : | IGF2BP2 |
| TF name : | KLF7 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| KLF7 | Hs_Cytokines_and_Inflammatory_Response_WP530_79331 | wikipathways | 21 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01807 | chr3:185824281-185824602 | Bone Marrow | hematopoietic stem cell | -- |